Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside

Anti-Cancer Drugs

Volumn 7, Issue 3, 1996, Pages 266-274

  Momparler, Richard L ^a,b   Laliberté, Josée ^a   Eliopoulos, Nicoletta ^a   Beauséjour, Christian ^a   Cournoyer, Denis ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Cytidine deaminase; Cytosine arabinoside; Drug resistance; Transfection

Indexed keywords

COMPLEMENTARY DNA; CYTARABINE; CYTIDINE DEAMINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TOXICITY; FIBROBLAST; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030013207     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199605000-00005     Document Type: Article

References (29)

1. Bertino 'Turning the tables' - making normal marrow resistant to chemotherapy. J Natl Cancer Inst 1990; 82: 1234-5.
2. Corey CA, DeSilva AD, Holland CA, Williams DA. Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 1990; 75: 337-43.
3. Banerjee D, Schweitizer BI, Volkenandt M, et al. Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance. Gene 1994; 139: 269-84.
4. McLachlin RR, Eglitis MA, Ueda K, et al. Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cell with the use of retroviral gene transfer. J Natl Cancer Inst 1990; 82: 1260-3.
5. Sorrentino BP, Brandt SJ, Bodine D, et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 1992; 257: 99-103.
6. Podda S, Ward M, Himelstein A, et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 1992; 89: 9676-80.
7. Greenbaum M, Letourneau S, Assar H, Scheeler RL, Batist G, Cournoyer D. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts. Cancer Res 1994; 54: 4442-7.
8. Camiener GW, Smith CG. Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. Biochem Pharmacol 1965; 14: 1405-16.
9. Müller WEG, Zahn RK. Metabolism of 1-β-D-arabinofuranosluracil in mouse L5178Y cells. Cancer Res 1979; 39; 1102-7.
10. Ho DHW, Frei E. Clinical pharmacology of 1-β-D-arabinofuranoslcytosine. Clin Pharmacol 1972; 12: 944-54.
11. Steuart CD, Burke PJ. Cytidine deaminase and the development of resistance to arabinosyl cytosine. Nature New Biol 1971; 233: 109-10.
12. Onetto N, Momparler RL, Momparler LF, Gyger M. In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-aza-2′-deoxycytidine. Semin Oncol 1987; 14: 231-7.
13. Bodey GP, Freireich EJ, Monto RW, Hewlett JS. Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. Cancer Chemotber Rep 1969; 53: 59-66.
14. Laliberté J, Momparler RL. Human cytidine deaminase: purification of enzyme, cloning, and expression of its cDNA. Cancer Res 1994; 54: 5401-7.
15. Jaffee EM, Dranoff G, Cohen LK, et al. High efficiency transfer into primary tumor explants without cell selection. Cancer Res 1993; 53: 2221-36.
16. Dwarki VJ, Belloni P, Nijar, T, et al. Gene therapy for hemophilia A: production of therapeutic levels of human factor Vin vivo in mice. Proc Natl Acad Sci USA 1995; 92: 1023-7.
17. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-24.
18. Miller AD, Miller DG, Carcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993; 217: 581-99-
19. Momparler RL, Laliberté J. Induction of cytidine dearninase in HL-60 myeloid leukemic cells by 5-azadeoxycytidine. Leukemia Res 1990; 14: 751-4.
20. Chomcynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-9.
21. Feinberg AP, Vogelstein BA. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
22. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. CABIOS 1988; 4: 181-6.
23. Ho DHW, Carter CJ, Brown NS, et al. Effects of tetrahydrouridine on the uptake and metabolism of 1-β-D-arabinofuranoslcytosine in human normal and leukemic cells. Cancer Res 1980; 40: 2441-46.
24. Kreis W, Chan K, Budman DR, et al. Effect of tetrahydrouridine on the clinical pharmacology of 1-β-D-arabinofuranoslcytosine when both drugs are coinfused over three hours. Cancer Res 1988; 48: 1337-42.
25. Momparler RL. Kinetic and template studies with 1-β-D-arabinofuranoslcytosine 5′-triphosphate and mammalian deoxyribonucleic acid polymerase. Mol Pharmacol 1972; 8: 362-70.
26. Rustum M, Riva C, Preisler HD. Pharmacokinetic parameters of 1-β-D-arabinofuranoslcytosine (Ara-C) and their relationship to intracellular metabolism of Ara-C, toxicity and response of patients with acute nonlymphocytic leukemia treated with conventional and high dose Ara-C. Semin Oncol 1987; 14 (suppl 1): 141-8.
27. Cappizi RL, Yang J-L, Cheng E, et al. Alteration of the pharmacokinetics of high dose Ara-C by its metabolite, high Ara-U in patients with acute leukemia. J Clin Oncol 1983; 1: 763-71.
28. Hauser J, Levin AS, Dickson K. Unique pattern of point mutations arising after gene transfer into mammalian cells. EMBO J 1987; 6: 63-7.
29. Karlsson S, Bodine DM, Perry L, Papayannopoulou T, Neihaus AW. Expression of the human beta glonin gene following retroviral mediated transfer into multipotential hematopoietic progenitors of mice. Proc Natl Acad Sci USA 1988; 85: 6062-6.